 |
|
End-stage Renal Disease in Specific Ethnic and Racial Groups
Risk Factors and Benefits of Antihypertensive Therapy
David R. Powers, MD;
J. David Wallin, MD
Arch Intern Med. 1998;158:793-800.
During the past few years, it has become apparent that there are factors that place a person at greater risk for the development and progression of renal failure. This has been documented since the early 1980s by the United States Renal Data System that has collected data confirming that end-stage renal disease occurs at a greater rate in certain subpopulations of Americans. It is evident from an examination of the data that African Americans and American Indians have an incidence of end-stage renal disease that is not proportional to their percentage of the total population. In fact, African Americans and American Indians are reported to have at least a 4-fold greater incidence of end-stage renal disease than white Americans. There have been 5 factors identified: hypertension, glucose intolerance, insulin resistance, salt sensitivity, and hyperlipidemia, which may play a greater role in these subpopulations. In addition, as with other populations, lifestyle issues may serve to alter these primary risk factors or may act as direct modulators of renal disease progression. There is also a possibility that interactions between risk factors frequently occur that may modify the development or progression of the disease. This article reviews these risk factors and emphasizes the interaction between hypertension and the other factors. In addition, the effects of antihypertensive agents on risk factors and on renal outcome are emphasized. Where possible, issues specific to African Americans and American Indians are underscored; however, one must accept that the database on these populations is only now developing. This review should help the clinician make appropriate choices when prescribing antihypertensive therapy for patients who may be at risk of developing progressive renal failure.
From the Section of Nephrology, Louisiana State University School of Medicine, New Orleans.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Racial/Ethnic Variations in Women's Health: The Social Embeddedness of Health
Williams
Am. J. Public Health 2008;98:S38-S47.
ABSTRACT
| FULL TEXT
Microalbuminuria in Insulin Sensitivity in Patients with Growth Hormone-Secreting Pituitary Tumor
Baldelli et al.
J. Clin. Endocrinol. Metab. 2008;93:710-714.
ABSTRACT
| FULL TEXT
Mechanical Forces in Diabetic Kidney Disease: A Trigger for Impaired Glucose Metabolism
Gnudi et al.
J. Am. Soc. Nephrol. 2007;18:2226-2232.
ABSTRACT
| FULL TEXT
The Relationship between Hyperinsulinemia, Hypertension and Progressive Renal Disease
El-Atat et al.
J. Am. Soc. Nephrol. 2004;15:2816-2827.
ABSTRACT
| FULL TEXT
An Explanation for the Increase in Heart Disease Mortality Rates in Diabetic Pima Indians: Effect of renal replacement therapy
Pavkov et al.
Diabetes Care 2004;27:1132-1136.
ABSTRACT
| FULL TEXT
Management of High Blood Pressure in African Americans: Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks
Douglas et al.
Arch Intern Med 2003;163:525-541.
FULL TEXT
Socio-economic status and chronic renal failure: a population-based case-control study in Sweden
Fored et al.
Nephrol Dial Transplant 2003;18:82-88.
ABSTRACT
| FULL TEXT
Race/Ethnicity and Cancer Survival: The Elusive Target of Biological Differences
Kiefe
JAMA 2002;287:2138-2139.
FULL TEXT
Racial/Ethnic Variations in Women's Health: The Social Embeddedness of Health
Williams
Am. J. Public Health 2002;92:588-597.
ABSTRACT
| FULL TEXT
Cardiac and renal damage in the elderly hypertensive
Ribstein et al.
Journal of Renin-Angiotensin-Aldosterone System 2002;3:S16-S24.
The management of hypertensive disease in Black patients
Gibbs et al.
QJM 1999;92:187-192.
ABSTRACT
| FULL TEXT
|
